Literature DB >> 32317126

Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR.

Jianhui Peng1, Mingke Wang2, Gangqing Zhang3, Eying Lu4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32317126      PMCID: PMC7151314          DOI: 10.1016/j.ajic.2020.03.017

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


× No keyword cloud information.
To the Editor: Since December 2019,the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gradually become a global health concern. As of March 23, 2020, 332,930 people had a confirmed infection and 14,510 people died worldwide. Up to now, respiratory droplets and close contact were considered as the major transmission route of COVID-19. Here, we report the clinical and epidemiological characteristics of 7 discharged patients who turned positive again (named as turn-positive patients) for SARS-CoV-2 on quantitative RT-PCR (qRT-PCR). The detailed timeline is presented in Appendix 1. On January 17, 2020, patient 1 (male, 67-year-old), who had travelled from Wuhan (Hubei, China) to Guangzhou (Guangdong, China), had a fever (37.8°C) and cough with abnormal chest X-ray images, and his throat swab was positive on qRT-PCR (January 24). Patient 2 (son-in-law of patient 1) had a fever (38.9°C) and chills but no cough with normal X-ray and positive throat swab (January 24). Patient 3 (wife of patient 1) had no fever (37.0°C) but cough, expectoration, normal X-ray, and positive throat swab (January 27). Patient 4 (grandson of patient 1) had no fever (36.3°C) but cough, normal X-ray, and positive throat swab (Jan 27). All patients were successively admitted to our hospital. After treatment for 18 days (patient 1 and 2), 19 days (patient 3), or 12 days (patient 4), they were discharged with no symptoms and normal imaging and qRT-PCR results (discharge criteria). On February 19, patient 1 was readmitted to our hospital with no symptoms but abnormal computed tomography (CT) images and positive qRT-PCR results. On Feb 22, patient 2, 3, and 4 were readmitted to our hospital with no symptoms, normal (patient 4) or abnormal CT images (patient 2 and 3), positive nasal swab but negative throat or anal swab on qRT-PCR. During the second hospitalization, nonorganic insomnia and increased anxiety was observed in patients 2 and 3. After treatment for 6 days(patient 1), 5 days(patient 2 and 4), or 7 days(patient 3), they were discharged but quarantined in our hospital. On January 24, patient 5 (female, 38-year-old), who returned to Guangzhou from Wuhan and on January 29, patient 6 (male, 29-year-old), whose father had returned to Guangzhou from Wuhan, presented with fever (37.5°C and 38.2°C, respectively) but no cough and had normal X-ray but positive throat swab. Patient 7 (female, 21-year-old) had a fever (37.3°C), itchy throat but no cough, normal X-ray but positive qRT-PCR results (January 31). Patients 5, 6, and 7 were admitted to our hospital. After treatment for 18 days (patient 5), 17 days (patient 6), or 15 days (patient 7), they met the discharge criteria and were discharged. Patients 5 and 6 moved to a hotel, whereas patient 7 went home. On February 22, patient 5 was readmitted to our hospital with no symptoms and normal X-ray but positive throat swab. On February 26, patient 6 was readmitted to our hospital with no symptoms, normal CT, and negative throat swab but positive anal swab. On February 24, patient 7 was readmitted to our hospital with no symptoms but abnormal CT, positive nasal swab but negative throat or anal swabs. During treatment, negative throat swab but positive anal swab was observed on patient 5 (February 24) and patient 6 (February 27, February 28, March 2, March 3, and March 4). After treatment for 8 days (patient 5), 10 days (patient 6), or 5 days (patient 7), they were discharged but quarantined in our hospital. These cases highlight important issues that need our immediate attention. First, all 7 turn-positive patients had shorter hospital stays, lower medical costs, and milder symptoms in their second hospital visit than in their first-time hospitalization (Appendix 2). These findings may be attributed to convalescent plasma as a potential therapy for SARS-CoV-2 infection, which will be beneficial in the fight against COVID-19. Second, positive anal swab but negative throat swab was observed in 2 turn-positive patients (patient 5 and 6), and the diagnostic value of anal swab test in late stage of infection requires further investigation. Meanwhile, fomite transmission and environmental contamination by COVID-19 patients should not be ignored.6, 7, 8 Imaging examination and qRT-PCR results were sometimes inconsistent, and therefore, a combination of these methods should be used for diagnoses. Four of the turn-positive patients (patient 1-4) were from one family, suggesting that the occurrence of turn-positive patients in family cluster is a non-negligible phenomenon. Furthermore, we should consider the possibility that the turn-positive patients were not completely cured the first time and were discharged based on a false-negative diagnostic test. To avoid false-negative diagnosis of positive patients, diagnostic tests with high specificity and sensitivity are urgently needed. Finally, nonorganic insomnia and increased anxiety was observed in 2 turn-positive patients (patient 2 and 3) indicating that timely mental health care for the SARS-CoV-2 infected patients is urgently needed, especially turn-positive patients who require rehospitalization and medical observation for 14 days after discharge. As a new infectious disease, the pathogenesis and epidemiological and clinical characteristics of SARS-CoV-2 infection is still not well understood. , Further studies on turn-positive patients infected with SARS-CoV-2 will deepen our understanding of the whole process of occurrence, development, and transformation ofCOVID-19.
  7 in total

1.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

2.  Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed.

Authors:  Yu-Tao Xiang; Yuan Yang; Wen Li; Ling Zhang; Qinge Zhang; Teris Cheung; Chee H Ng
Journal:  Lancet Psychiatry       Date:  2020-02-04       Impact factor: 27.083

3.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

4.  Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests.

Authors:  Chunbao Xie; Lingxi Jiang; Guo Huang; Hong Pu; Bo Gong; He Lin; Shi Ma; Xuemei Chen; Bo Long; Guo Si; Hua Yu; Li Jiang; Xingxiang Yang; Yi Shi; Zhenglin Yang
Journal:  Int J Infect Dis       Date:  2020-02-27       Impact factor: 3.623

5.  Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.

Authors:  Dabiao Chen; Wenxiong Xu; Ziying Lei; Zhanlian Huang; Jing Liu; Zhiliang Gao; Liang Peng
Journal:  Int J Infect Dis       Date:  2020-03-05       Impact factor: 3.623

6.  Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool.

Authors:  Yu He; Zhengli Wang; Fang Li; Yuan Shi
Journal:  J Infect       Date:  2020-03-05       Impact factor: 6.072

7.  Convalescent plasma as a potential therapy for COVID-19.

Authors:  Long Chen; Jing Xiong; Lei Bao; Yuan Shi
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071

  7 in total
  20 in total

1.  Breath-, air- and surface-borne SARS-CoV-2 in hospitals.

Authors:  Lian Zhou; Maosheng Yao; Xiang Zhang; Bicheng Hu; Xinyue Li; Haoxuan Chen; Lu Zhang; Yun Liu; Meng Du; Bochao Sun; Yunyu Jiang; Kai Zhou; Jie Hong; Na Yu; Zhen Ding; Yan Xu; Min Hu; Lidia Morawska; Sergey A Grinshpun; Pratim Biswas; Richard C Flagan; Baoli Zhu; Wenqing Liu; Yuanhang Zhang
Journal:  J Aerosol Sci       Date:  2020-10-15       Impact factor: 3.433

2.  Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature.

Authors:  Anna Gidari; Marco Nofri; Luca Saccarelli; Sabrina Bastianelli; Samuele Sabbatini; Silvia Bozza; Barbara Camilloni; Igino Fusco-Moffa; Claudia Monari; Edoardo De Robertis; Antonella Mencacci; Daniela Francisci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-10       Impact factor: 3.267

Review 3.  SARS-CoV-2 reinfection and implications for vaccine development.

Authors:  Firzan Nainu; Rufika Shari Abidin; Muh Akbar Bahar; Andri Frediansyah; Talha Bin Emran; Ali A Rabaan; Kuldeep Dhama; Harapan Harapan
Journal:  Hum Vaccin Immunother       Date:  2020-12-01       Impact factor: 3.452

Review 4.  Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.

Authors:  Xiujuan Tang; Salihu S Musa; Shi Zhao; Daihai He
Journal:  Front Public Health       Date:  2021-06-11

5.  ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.

Authors:  Agnès Marchio; Christophe Batejat; Jessica Vanhomwegen; Maxence Feher; Quentin Grassin; Maxime Chazal; Olivia Raulin; Anne Farges-Berth; Florence Reibel; Vincent Estève; Anne Dejean; Nolwenn Jouvenet; Jean-Claude Manuguerra; Pascal Pineau
Journal:  Arch Virol       Date:  2021-07-12       Impact factor: 2.574

6.  Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.

Authors:  Ejun Peng; Ding Xia; Wenxi Gao; Ying Zhan; Huan Yang; Xiaoqi Yang; Hua Xu; Xiaoling Qu; Jie Sun; Shaogang Wang; Zhangqun Ye; Kun Tang; Zhiqiang Chen
Journal:  Eur Urol Open Sci       Date:  2020-07-30

Review 7.  Discharged COVID-19 patients testing positive again for SARS-CoV-2 RNA: A minireview of published studies from China.

Authors:  Zhiyong Han; Fortunato Battaglia; Stanley R Terlecky
Journal:  J Med Virol       Date:  2020-10-07       Impact factor: 20.693

8.  The treatment and follow-up of 'recurrence' with discharged COVID-19 patients: data from Guizhou, China.

Authors:  Maolu Tian; Yanjun Long; Yang Hong; Xiangyan Zhang; Yan Zha
Journal:  Environ Microbiol       Date:  2020-07-29       Impact factor: 5.476

9.  SARS-CoV-2 re-infection: a case report from Qatar.

Authors:  Alanoud AlFehaidi; Syed Ali Ahmad; Ehab Hamed
Journal:  J Infect       Date:  2020-10-25       Impact factor: 6.072

Review 10.  Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.

Authors:  Thi Loi Dao; Van Thuan Hoang; Philippe Gautret
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-28       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.